Cargando…

Editorial: Novel therapeutic approaches for the treatment of ocular disease, Volume II

Detalles Bibliográficos
Autores principales:	Thermos, Kyriaki, Joachim, Stephanie C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9752055/ https://www.ncbi.nlm.nih.gov/pubmed/36532770 http://dx.doi.org/10.3389/fphar.2022.1104105

Ejemplares similares

Editorial: Novel approaches to the treatment of multidrug-resistant bacteria, Volume II
por: Pusparajah, Priyia, et al.
Publicado: (2022)

Editorial: Medicinal Cannabis: evolution of therapeutic use, future approaches and other implications, volume II
por: Baratta, Francesca, et al.
Publicado: (2023)

Editorial: Natural products as an emerging therapeutic alternative for the treatment of anxiety and depression, Volume II
por: Khan, Ajmal, et al.
Publicado: (2022)

Editorial: Apoptosis Induction/Suppression: A Feasible Approach for Natural Products to Treatment of Diseases, Volume II
por: Peng, Wei, et al.
Publicado: (2022)

Editorial: Pharmacological approaches targeting neutrophilic inflammation: Volume II
por: Sokolov, Alexey V., et al.
Publicado: (2022)

Editorial: Cannabidiol treatment in neurotherapeutic interventions, volume II
por: Gonzalez-Cuevas, Gustavo, et al.
Publicado: (2023)

Editorial: Modulating lymphatic vascular growth in disease: current and potential pharmacological approaches for prevention and treatment, Volume II
por: Trevaskis, Natalie L., et al.
Publicado: (2023)

Editorial: Autophagy in inflammation related diseases, volume II
por: Shao, Bo-Zong, et al.
Publicado: (2023)

Editorial: Antimycobacterial drug discovery: molecular therapeutics and target identification, Volume II
por: Gunosewoyo, Hendra, et al.
Publicado: (2023)

Editorial: Neuroprotection and disease modification in Parkinson’s disease: Volume II
por: Otero-Losada, Matilde, et al.
Publicado: (2023)

Editorial: Purinergic pharmacology, Volume II
por: Ciruela, Francisco, et al.
Publicado: (2023)

Editorial: Eicosanoids in cancer, Volume II
por: Patrignani, Paola, et al.
Publicado: (2023)

Editorial: New insights into renal fibrosis and therapeutic effects of natural products volume II
por: Chen, Dan-Qian, et al.
Publicado: (2022)

Editorial: Chronic Inflammation and Neurodegeneration in Retinal Disease, Volume II
por: Bucolo, Claudio, et al.
Publicado: (2022)

Editorial: Chemoinformatics Approaches to Structure- and Ligand-Based Drug Design, Volume II
por: Ferreira, Leonardo L. G., et al.
Publicado: (2022)

Editorial: Therapeutic Index for Nutraceuticals in Inflammation-Related Diseases: Efficacy, Bioavailability, Metabolism and Interactions With Drugs, Volume II
por: Peluso, Ilaria, et al.
Publicado: (2022)

Dendrimers as tunable vectors of drug delivery systems and biomedical and ocular applications
por: Kalomiraki, Marina, et al.
Publicado: (2015)

Editorial: Antimalarial chemotherapy in the XXIst century, volume II
por: Gomes, Paula, et al.
Publicado: (2023)

Editorial: Chronic inflammation and pharmacological interventions in cardiovascular diseases, volume II
por: Yan, Aiwei, et al.
Publicado: (2023)

Editorial: Herbal medicines for gastrointestinal and hepatic diseases - novel pharmacological and toxicological approaches, Volume I
por: Hasnat, Muhammad, et al.
Publicado: (2023)

Editorial: The roles of ion-induced cell death in cancer treatment: volume II
por: Zhang, Kui, et al.
Publicado: (2023)

Editorial: Role of Nrf2 in Disease: Novel Molecular Mechanisms and Therapeutic Approaches
por: Egea, Javier, et al.
Publicado: (2019)

Editorial: Molecular mechanisms and new therapeutic targets in epithelial to mesenchymal transition (EMT) and fibrosis, volume II
por: Battistelli, Cecilia, et al.
Publicado: (2022)

Editorial: Venoms, animal and microbial toxins, volume II
por: Cao, Zhijian, et al.
Publicado: (2022)

Editorial: Current Aspects in Chemopreventive Strategies, Volume II
por: Tuli, Hardeep Singh, et al.
Publicado: (2022)

Editorial: Applications of herbal medicine to control chronic kidney disease: Volume II
por: Chen, Jianping, et al.
Publicado: (2022)

Editorial: Bone and Cartilage Diseases – The Role and Potential of Natural Products, Volume II
por: Pei, Ming, et al.
Publicado: (2023)

Editorial: Novel therapeutic approaches to target drug resistant tumors
por: Riganti, Chiara, et al.
Publicado: (2023)

Editorial: Imaging technology in oncology pharmacological research, volume II
por: Zeng, Qi, et al.
Publicado: (2022)

Editorial: Hydrogen sulfide: Physiology, Pharmacology and Toxicology, Volume II
por: Bian, Jin-Song
Publicado: (2022)

Editorial: Resolution of inflammation: Mechanisms, mediators and biomarkers: Volume II
por: Patrignani, Paola, et al.
Publicado: (2022)

Editorial: Neurodegeneration, cell signaling and neuroreparative strategies, Volume II
por: Vaz, Ana Rita, et al.
Publicado: (2023)

Editorial: Microbiome in IBD: From Composition to Therapy, Volume II
por: Liu, Ning-Ning, et al.
Publicado: (2023)

Editorial: Experimental models of epilepsy and related comorbidities, Volume II
por: Shaikh, Mohd Farooq, et al.
Publicado: (2023)

Editorial: Medication safety in COVID-19 management, Volume II
por: Das, Saibal
Publicado: (2023)

Editorial: Receptor biology and cell signaling in diabetes: volume II
por: Srivastava, Swayam Prakash, et al.
Publicado: (2023)

Editorial: Natural products and brain energy metabolism: Astrocytes in neurodegenerative diseases Volume II
por: Wang, Fushun, et al.
Publicado: (2023)

Editorial: New trends in natural product research for inflammatory and infectious diseases: Volume II
por: Ribeiro-Filho, Jaime, et al.
Publicado: (2023)

Editorial: Innovation in ocular pharmacology
por: Gozzo, Lucia, et al.
Publicado: (2023)

Editorial: Novel Therapeutic Targets and Emerging Treatments for Fibrosis
por: Samuel, Chrishan S., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_lhnchtjkal4lb00h005il9kv37